Menu
GeneBe

rs114819130

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_001875.5(CPS1):​c.449G>A​(p.Gly150Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0104 in 1,613,504 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G150G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0061 ( 4 hom., cov: 32)
Exomes 𝑓: 0.011 ( 114 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

1
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 3.65
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a region_of_interest Anthranilate phosphoribosyltransferase homolog (size 179) in uniprot entity CPSM_HUMAN there are 27 pathogenic changes around while only 9 benign (75%) in NM_001875.5
BP4
Computational evidence support a benign effect (MetaRNN=0.014847696).
BP6
Variant 2-210577488-G-A is Benign according to our data. Variant chr2-210577488-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 334013.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=5, Benign=2}. Variant chr2-210577488-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00613 (933/152128) while in subpopulation NFE AF= 0.0101 (685/67998). AF 95% confidence interval is 0.00945. There are 4 homozygotes in gnomad4. There are 420 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPS1NM_001875.5 linkuse as main transcriptc.449G>A p.Gly150Glu missense_variant 4/38 ENST00000233072.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPS1ENST00000233072.10 linkuse as main transcriptc.449G>A p.Gly150Glu missense_variant 4/381 NM_001875.5 P1P31327-1

Frequencies

GnomAD3 genomes
AF:
0.00614
AC:
933
AN:
152010
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00414
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00499
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00639
AC:
1605
AN:
251346
Hom.:
4
AF XY:
0.00635
AC XY:
863
AN XY:
135840
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00460
Gnomad ASJ exome
AF:
0.0111
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.00376
Gnomad FIN exome
AF:
0.00383
Gnomad NFE exome
AF:
0.00937
Gnomad OTH exome
AF:
0.00816
GnomAD4 exome
AF:
0.0108
AC:
15828
AN:
1461376
Hom.:
114
Cov.:
31
AF XY:
0.0107
AC XY:
7780
AN XY:
727006
show subpopulations
Gnomad4 AFR exome
AF:
0.00149
Gnomad4 AMR exome
AF:
0.00400
Gnomad4 ASJ exome
AF:
0.0119
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00424
Gnomad4 FIN exome
AF:
0.00404
Gnomad4 NFE exome
AF:
0.0126
Gnomad4 OTH exome
AF:
0.0112
GnomAD4 genome
AF:
0.00613
AC:
933
AN:
152128
Hom.:
4
Cov.:
32
AF XY:
0.00565
AC XY:
420
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.00197
Gnomad4 AMR
AF:
0.00413
Gnomad4 ASJ
AF:
0.0104
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00499
Gnomad4 FIN
AF:
0.00255
Gnomad4 NFE
AF:
0.0101
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00935
Hom.:
12
Bravo
AF:
0.00620
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.0117
AC:
45
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0124
AC:
107
ExAC
AF:
0.00633
AC:
768
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0103

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Congenital hyperammonemia, type I Benign:4
Benign, no assertion criteria providedclinical testingNatera, Inc.Jan 10, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 15, 2017- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024CPS1: BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2021This variant is associated with the following publications: (PMID: 18666241) -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 09, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
CPS1-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesOct 12, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.68
D;.;D;D
Eigen
Benign
0.16
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.81
T;D;D;D
MetaRNN
Benign
0.015
T;T;T;T
MetaSVM
Uncertain
0.46
D
MutationTaster
Benign
0.99
D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-4.8
D;D;D;.
REVEL
Uncertain
0.63
Sift
Uncertain
0.0010
D;D;D;.
Sift4G
Uncertain
0.028
D;D;D;T
Polyphen
0.53
.;.;P;.
Vest4
0.76, 0.72, 0.71
MVP
0.95
MPC
0.58
ClinPred
0.063
T
GERP RS
4.4
Varity_R
0.88
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114819130; hg19: chr2-211442212; COSMIC: COSV99028192; COSMIC: COSV99028192; API